Literature DB >> 20683326

Triglyceride lipases and atherosclerosis.

Gunilla Olivecrona1, Thomas Olivecrona.   

Abstract

PURPOSE OF REVIEW: There are strong epidemiologic connections between plasma triglycerides and atherosclerosis. We will consider to what extent this goes back to derangements of the lipoprotein lipase (LPL) system. The roles of hepatic lipase and endothelial lipase will also be touched upon. RECENT
FINDINGS: Understanding of LPL action has taken major steps with the discovery of lipase maturation factor 1 as a specific endoplasmic reticulum chaperon needed for proper folding of the lipases, glycosylphosphatidylinositol-anchored HDL-binding protein 1 as an endothelial cell protein needed for transport and binding of LPL and some angiopoietin-like proteins that can modulate LPL activity. Studies of genetic variants continue to support the important roles of the lipases in lipoprotein metabolism and in atherosclerosis.
CONCLUSION: There are several ways by which derangement of the lipases may contribute to atherogenesis. Lipase actions are major determinants of plasma lipoprotein patterns. LPL activity must be modulated in relation to the physiological situation (feeding, fasting, exercise, etc.). Fatty acids and monoglycerides generated must be efficiently removed so that they do not endanger the integrity of the endothelium, cause lipotoxic reactions or both. In addition, the lipases may cause binding and endocytosis of lipoprotein particles in the artery wall.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683326     DOI: 10.1097/MOL.0b013e32833ded83

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  15 in total

1.  Determination of lipoprotein lipase activity using a novel fluorescent lipase assay.

Authors:  Debapriya Basu; Jahan Manjur; Weijun Jin
Journal:  J Lipid Res       Date:  2011-01-26       Impact factor: 5.922

2.  Combinatorial regulation of lipoprotein lipase by microRNAs during mouse adipogenesis.

Authors:  Maria Bouvy-Liivrand; Merja Heinäniemi; Elisabeth John; Jochen G Schneider; Thomas Sauter; Lasse Sinkkonen
Journal:  RNA Biol       Date:  2014-01-16       Impact factor: 4.652

3.  Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.

Authors:  Mikael Larsson; Evelina Vorrsjö; Philippa Talmud; Aivar Lookene; Gunilla Olivecrona
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

4.  Association between the MARS rs6782181 polymorphism and serum lipid levels.

Authors:  Jian Wu; Rui-Xing Yin; Tao Guo; Quan-Zhen Lin; Guang-Yuan Shi; Jia-Qi Sun; Shao-Wen Shen; Yi-Ming Wang; Hui Li; Jin-Zhen Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

5.  Lysosomes, cholesterol and atherosclerosis.

Authors:  W Gray Jerome
Journal:  Clin Lipidol       Date:  2010-12-01

Review 6.  The role of triglycerides in atherosclerosis.

Authors:  Beatriz G Talayero; Frank M Sacks
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

Review 7.  A new, powerful player in lipoprotein metabolism: brown adipose tissue.

Authors:  Alexander Bartelt; Martin Merkel; Joerg Heeren
Journal:  J Mol Med (Berl)       Date:  2012-01-10       Impact factor: 4.599

Review 8.  Triglycerides and heart disease: still a hypothesis?

Authors:  Ira J Goldberg; Robert H Eckel; Ruth McPherson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-28       Impact factor: 8.311

9.  LncRNA HDAC11-AS1 Suppresses Atherosclerosis by Inhibiting HDAC11-Mediated Adropin Histone Deacetylation.

Authors:  Liang Li; Wei Xie
Journal:  J Cardiovasc Transl Res       Date:  2022-05-03       Impact factor: 4.132

Review 10.  Endothelial fatty acid transport: role of vascular endothelial growth factor B.

Authors:  Carolina Hagberg; Annika Mehlem; Annelie Falkevall; Lars Muhl; Ulf Eriksson
Journal:  Physiology (Bethesda)       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.